Science and Enterprise

Tag: USPTO

  • Patent Awarded for Non-Medicinal Emphysema Treatment

    Aeris Therapeutics in Woburn, Massachusetts has received a patent for its  lung volume reduction technology to treat emphysema with a polymer-based hydrogel. Patent number 8,198,365 was awarded earlier this week by the U.S. Patent and Trademark Office to four inventors and assigned to Aeris Therapeutics. Emphysema is a form of chronic obstructive pulmonary disease, often triggered…

  • Patent Awarded for Curry Compound as Drug Ingredient

    A patent has been awarded for compounds based on a substance in the spices curry and turmeric, to use in treatments for a number of diseases, including some cancers. Patent number 8,198,323 was awarded yesterday by the U.S. Patent and Trademark Office to nine inventors, and assigned to University of Rochester in New York, University…

  • Patent Awarded for Sustained Release Drug Implant in Eyes

    The company pSivida Corp., a medical device developer in Watertown, Massachusetts, has received a patent for its system to continuously deliver drugs to the eyes. The U.S. Patent and Trademark Office awarded patent number 8,192,408 yesterday (5 June) to four inventors, including pSivida vice-presidents Martin Nazzaro and Hong Guo, and assigned it to pSivida. The…

  • Patent Issued on Antibody for Brain, Spinal Cord Treatments

    Lpath Inc., a biotechnology company in San Diego, has been awarded a patent for its monoclonal antibody against lysophosphatidic acid, a factor in neurological disorders such as traumatic brain and spinal cord injuries. Patent 8,158,124 was issued last week by the U.S. Patent and Trademark Office to four inventors, including Lpath’s chief scientist Roger Sabbadini,…

  • Patent Issued for Technology to Suppress Stem Cell Rejection

    Athersys Inc., a biotechnology company in Cleveland, Ohio, has received a patent for its process to reduce or suppress graft-versus-host disease associated with bone-marrow stem cell transplants used to treat leukemia and related disorders. Patent 8,147,824 was issued yesterday by the U.S. Patent and Trademark Office and assigned to Athersys, as well as the Oregon…

  • U.S. Patent Awarded for Airborne Pathogen Diagnostic Device

    PositiveID Corporation in Delray Beach, Florida says it has received a patent on a key element of its technology to test for airborne bacteria and viruses and deliver results within 30 minutes. The U.S. Patent and Trademark Office awarded patent no. 8,133,451 for the technology on 13 March 2012 and assigned it to Microfluidics Systems,…

  • U.S. Patent Awarded for Isobutanol Production Process

    The U.S. Patent and Trademark Office has granted Gevo Inc. in Englewood, Colorado, a maker of biofuels from renewable feedstocks, a patent for its process of producing isobutanol with reduced accumulation of by-products. Patent no. 8,133,715, “Reduced By-Product Accumulation for Improved Production of Isobutanol,” was awarded today to 12 inventors and assigned to Gevo. Isobutanol…

  • Patent Issued for Protein-Engineered Flu Vaccine Technology

    Fraunhofer USA in Newark, Delaware has been assigned a U.S. patent for its technology that binds proteins with antigens to fight influenza. The Patent and Trademark Office awarded patent 8,124,103 on 28 February to three inventors, including Vidadi Yusibov, executive director of Fraunhofer USA. Yusibov also serves as the chief scientific officer of iBio Inc.,…

  • One-Step Process Developed to Produce Multi-Color Polymer

    Researchers from University at Buffalo in New York have developed a simple, inexpensive process for generating a polymer that emits many different wave-lengths of light. The findings from Buffalo’s engineering department appear online in the journal Advanced Materials (paid subscription required), for which a provisional U.S. patent application has been filed. The engineers, led by…

  • Patent Awarded for Migraine Drug Inhalation Method

    MAP Pharmaceuticals Inc. in Mountain View, California says it received a U.S. patent for its formulation and method of administering the drug dihydroergotamine (DHE) used to treat migraine headaches. Patent 8,119,639 from the U.S. Patent and Trademark Office was awarded to four inventors including Thomas Armer, MAP Pharmaceuticals’s chief scientific officer. DHE is a type…